Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax Inc (NQ: NVAX )

9.120 -0.230 (-2.46%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novavax Inc

< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
59 60 Next >
Novavax Is a Buy on Recent Developments and Cheap Valuation
NVAX stock is one of the major players in the vaccine market, which is one that is expected to grow substantially over the next few years. 
Via InvestorPlace
4 Pharma Stocks to Buy Even if the Pandemic Ends
Here are four pharma stocks that looks attractive for the long-term. Deep product development pipelines will ensure steady revenue and cash flow growth. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Production Updates Could Give Novavax Stock a Big Boost
Given the low expectations for Novavax's deliveries, better-than-expected numbers could send the NVAX stock price back to the triple digits. 
Via InvestorPlace
Check Out What Whales Are Doing With NVAX
Someone with a lot of money to spend has taken a bearish stance on Novavax (NASDAQ:NVAX). And retail traders should know. We noticed this today when the big position showed up on publicly available... 
Via Benzinga
Novavax Stock’s Wild Moves Leave Little Room for Error
NVAX stock can still bring profits for traders and investors as long as they are willing to accept the risks that it brings. 
Via InvestorPlace
Why I’m Done With Novavax Stock
Management is terrible at delivering on its promises and even good news has failed to translate into higher prices for NVAX stock. 
Via InvestorPlace
Novavax Whale Trades Spotted
A whale with a lot of money to spend has taken a noticeably bearish stance on Novavax. Looking at options history for Novavax (NASDAQ:NVAX) we detected 11 strange trades. 
Via Benzinga
After Being Unloved on Wall Street, Novavax Deserves a Shot
NVAX stock was a darling of the markets once and could be again, given Novavax's recent progress in advancing Covid-19 vaccines globally. 
Via InvestorPlace
Why Novavax Has Limited Downside from Here
As countries potentially adopt a once yearly vaccination booster schedule for Covid-19, you can expect steady earnings for NVAX stock. 
Via InvestorPlace
Dump Novavax Stock as Delays May Make Its Vaccine Practically Obsolete
NVAX stock's price continues to slide lower as the prospects of its Covid-19 vaccine getting approved in the U.S. grow dim. 
Via InvestorPlace
Novavax's COVID-19 Vaccine Scores Canadian Approval
Health Canada approves Novavax Inc's (NASDAQ: NVAX) Nuvaxovid COVID-19 Vaccine in individuals 18 years of age and older. The vaccine, also known as NVX-... 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
This Reopening Stock Has A Better 1-Year Return Than Moderna, Pfizer, BioNTech, Novavax And Vaxart
Macy's Inc (NYSE:M) retail stores have something for everyo... 
Via Benzinga
Novavax Stock Is at Risk Despite Positive Poll Results
A recent poll supports Novavax's Covid treatment in the United States, but the vote on today's NVAX stock price chart warns against buying. 
Via InvestorPlace
Novavax Just Can’t Get it Together
Patient investors will wait for NVAX stock to hit another low or for the FDA to approve its Covid-19 vaccine before investing. 
Via InvestorPlace
Novavax Stock Has Growth Ahead Whether It Missed the Boat or Not
NVAX stock has been derided as a ran in the vaccine race, avoid that narrative and remain optimistic because the best is ahead for Novavax. 
Via InvestorPlace
Shipment Delays Threaten the Best Advantage Novavax Has
The latest setback for NVAX stock is lower than expected delivery numbers for its Covid-19 vaccine. The longer it takes to get its vaccine into arms, the more it risks losing a critical advantage. 
Via InvestorPlace
52 Biggest Movers From Yesterday
Gainers BioDelivery Sciences International, Inc. (NASDAQ: BDSI) shares climbed 52.8% to close at $5.56 on Monday. Collegium Pharmaceutical will acquire BioDelivery Sciences... 
Via Benzinga
What Are Whales Doing With Novavax
A whale with a lot of money to spend has taken a noticeably bearish stance on Novavax. Looking at options history for Novavax (NASDAQ:NVAX) we detected 23 strange trades. 
Via Benzinga
32 Stocks Moving In Monday's Mid-Day Session
Gainers BioDelivery Sciences International, Inc. (NASDAQ: BDSI) shares jumped 51.9% to $5.53. Collegium Pharmaceutical will acquire BioDelivery Sciences International at $5.60... 
Via Benzinga
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news flow continued to dominate... 
Via Talk Markets
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news... 
Via Benzinga
The Daily Biotech Pulse: Adcom Recommends Additional Trials For Lilly's Partnered Cancer Drug, Novavax Touts Pediatric Vaccine Data, TC Biopharm IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adcom Rules That Lilly May Have To Conduct Additional Studies For Co-... 
Via Benzinga
Novavax's COVID-19 Vaccine Shows 80% Effectiveness In Adolescent Study
Novavax Inc (NASDAQ: NVAX) said that its two-dose COVID-19 vaccine was 80% overall effective against COVID-19 in a late-stage trial testing the shot in teens aged... 
Via Benzinga
Novavax Stock Is a Buy After This Overdone Sell-Off
NVAX stock dropped too sharply on a negative Reuters article about Novavax, creating a great buying opportunity for investors. 
Via InvestorPlace
The Resumption Of Negotiations Between The U.S. And Iran May Lead To Lower Oil Prices
The US stock indices closed on the plus side on Tuesday. 
Via Talk Markets
Take a Leap Into Novavax Stock After Vaccine Sales Start
Novavax is worth speculating on at current levels. NVAX stock has fallen below the $100 mark ahead of its global Covid-19 vaccine launch. 
Via InvestorPlace
Rumble SPAC News: 14 Things to Know About the Joe Rogan Offer Giving CFVI Stock a Rise
CF Acquisition (CFVI) stock is getting a boost Tuesday on news of SPAC merger target Rumble making an offer to Joe Rogan. 
Via InvestorPlace
51 Biggest Movers From Yesterday
Also check out this: Apple And 3 Other Stocks Sold By Insiders Losers SelectQuote, Inc. (NYSE: SLQT) shares tumbled 47.3% to close at $3.44 on Tuesday after the company... 
Via Benzinga
< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
59 60 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.